Posted 27 May 2005 - 12:50 PM
I'm not sure that's a viable option Dave, because the structures that accumulate these crosslinks are the really long-lived ones with essentially no capacity for regeneratiion, like the lens of the eye and the walls of the major arteries.
Personally I think the small-molecule approach can probably be pushed a lot further than it has so far. There is a decidedly unhealthy reluctance among glycation experts in academia to work on it, but the most abundant such crosslinks have the key requirements of being (a) structurally unlike any physiological molecule, hence likely to be cleavable by drugs that are otherwise essentially harmless, and (b) rather unstable (in particular, acid-labile) so not necessarily refractory for thermodynamic reasons. (Some of the best-known links, such as pentosidine, are extremely stable (which is why they were found first, by methods involving acid hydrolysis) but they're much less abundant than glucosepane for example, and probably also than alpha-dicarbonyl links which are the ones ALT-711 is supposed to cleave.)